CRSP Earnings: *Mon 9-NOV-2026
|
End of day quotes updated Mon Oct 26 15:48 CST
🏠
🔍
|
| 26-Oct-2026 |
49.01 |
-0.38 {-0.8 %} |
V: 1,065,506 |
|
| CRSP |
26-Oct-2026 |
Close: 49.01 |
-0.38 {-0.8 %} |
Volume: 1,065,506 |
|
|
|
|
|
|
|
|
24-Sep-2026
29-May-2026
31-Dec-2025
31-Mar-2023
|
|
|
|
|
|
CRSP
|
SPY
|
|
-0.8
-0.8
-11.4
-11.4
-6.5
|
0.7
0.7
0.4
0.4
12.2
|
|
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
|
SPY tracks S&P 500 index.
|
|
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
|
| CRSP News | 24-Oct-2026 - Yahoo Finance
CRISPR Therapeutics (CRSP) Promotes Andrew Silver To CFO As Raju Prasad Resigns
CRISPR Therapeutics (NasdaqGM:CRSP) has promoted Andrew J. Silver to Chief Financial Officer, effective October 19, 2026. | 22-Oct-2026 - Yahoo Finance
The Outlook of CRISPR Therapeutics Stock Does Not Look Strong After Its CFO Resigns
Learn more A concept image of a white brain on a blue background surrounded by colorful pills by Tanita_St via Shutterstock CRISPR Therapeutics' (CRSP) CFO recently resigned, potentially signaling ... | 22-Oct-2026 - Barchart
The outlook of CRISPR Therapeutics stock does not look strong after its CFO resigns
CFO recently resigned, potentially signaling that CRSP stock could be heading for a downturn. Further, the shares are ... | 21-Oct-2026 - Yahoo Finance
Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
The average brokerage recommendation (ABR) for CRISPR Therapeutics (CRSP) is equivalent to a Buy. The overly optimistic ... | 17-Oct-2026 - The Motley Fool
Cathie Wood bought more CRISPR Therapeutics stock 2 days in a row. Here's what she sees in the biotech stock.
Billionaire investor Cathie Wood, through her ARK ETFs, made big buys of CRISPR Therapeutics on Friday, Oct. 9, and Monday, ... | 14-Oct-2026 - Yahoo Finance
Is CRISPR Therapeutics (CRSP) Undervalued As CASGEVY Hopes Face Market Doubts?
CRISPR Therapeutics (CRSP) recently saw its stock decline 3.45%, trailing the broader market, after fresh attention on ... | 13-Oct-2026 - Yahoo Finance
CRISPR Therapeutics (CRSP) Stock Looks Rich On Upcoming CTX310 Trial Data
CRISPR Therapeutics has seen its share price under pressure in recent years, even as fresh clinical data like the planned ... | 12-Oct-2026 - Yahoo Finance
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that ... | 24-Sep-2026 - Yahoo Finance
CRISPR Therapeutics (CRSP) Stock Looks Fully Valued As Book Value Questions Linger
CRISPR Therapeutics has seen its share price move around over the years, leaving investors with a mixed track record and a ... | | | |
Disclaimer
Privacy
Contact
Copyright © 2001-2026, All rights reserved.
HotCandlestick.com, LLC
|
